(b)(4).Catalog number is the similar us list number, the international list number is unknown.The device manufacturer and lot number of the device involved in this complaint was not provided.Therefore, it is unknown if the device involved was abbvie branded tubing.Abbvie has chosen to report this complaint due to the potential that the device involved could have been abbvie branded tubing.The device involved in the event was not returned; therefore, a return sample evaluation is unable to be performed.Intestinal occlusion is a known complication of a peg- j tube placement.Due to the report originating from a literature article, it is unlikely we will receive additional information.If any further relevant information is identified or obtained, a supplemental medwatch will be filed.
|
On an unknown date, a patient in (b)(6) underwent a procedure for the placement of percutaneous endoscopic gastrostomy (peg) tube with jejunal (peg-j) tube.In a literature article, it was reported that the patient was treated with levodopa-carbidopa intestinal gel (lcig) for parkinson's disease, experienced gastrointestinal disorder and died.The patient died for intestinal occlusion three months after lcig start.
|